|
1.
|
Driscoll DF, Newton DW, Bistrian BR. Potential hazards of precipitation associated with calcium chloride in parenteral nutrition admixtures: response to migaki et Al. JPEN J Parenter Enteral Nutr. 2012 Sep; 36(5):497-8.
|
|
|
|
|
2.
|
Martin CR, Dasilva DA, Cluette-Brown JE, Dimonda C, Hamill A, Bhutta AQ, Coronel E, Wilschanski M, Stephens AJ, Driscoll DF, Bistrian BR, Ware JH, Zaman MM, Freedman SD. Decreased Postnatal Docosahexaenoic and Arachidonic Acid Blood Levels in Premature Infants are Associated with Neonatal Morbidities. J Pediatr. 2011 Nov; 159(5):743-749.e2.
|
|
|
|
|
3.
|
Driscoll DF, Silvestri AP, Bistrian BR. Stability of MCT/LCT-based total nutrient admixtures for neonatal use over 30 hours at room temperature: applying pharmacopeial standards. JPEN J Parenter Enteral Nutr. 2010 May-Jun; 34(3):305-12.
|
|
|
|
|
4.
|
Joy J, Silvestri AP, Franke R, Bistrian BR, Nehne J, Newton DW, Driscoll DF. Calcium and phosphate compatibility in low-osmolarity parenteral nutrition admixtures intended for peripheral vein administration. JPEN J Parenter Enteral Nutr. 2010 Jan-Feb; 34(1):46-54.
|
|
|
|
|
5.
|
Driscoll DF, Ling PR, Bistrian BR. Pharmacopeial compliance of fish oil-containing parenteral lipid emulsion mixtures: Globule size distribution (GSD) and fatty acid analyses. Int J Pharm. 2009 Sep 8; 379(1):125-30.
|
|
|
|
|
6.
|
Driscoll DF, Thoma A, Franke R, Klütsch K, Nehne J, Bistrian BR. Lipid globule size in total nutrient admixtures prepared in three-chamber plastic bags. Am J Health Syst Pharm. 2009 Apr 1; 66(7):649-56.
|
|
|
|
|
7.
|
Singh H, Dumas GJ, Silvestri AP, Young S, Martin CR, Bistrian BR, Driscoll DF. Physical compatibility of neonatal total parenteral nutrition admixtures containing organic calcium and inorganic phosphate salts in a simulated infusion at 37 degrees C. Pediatr Crit Care Med. 2009 Mar; 10(2):213-6.
|
|
|
|
|
8.
|
Driscoll DF. Pure long-chain triglyceride emulsion exhibited physicochemical stability in parenteral all-in-one admixtures for neonates. JPEN J Parenter Enteral Nutr. 2009 Jul-Aug; 33(4):451-2.
|
|
|
|
|
9.
|
Driscoll DF, Ling PR, Andersson C, Bistrian BR. Hepatic indicators of oxidative stress and tissue damage accompanied by systemic inflammation in rats following a 24-hour infusion of an unstable lipid emulsion admixture. JPEN J Parenter Enteral Nutr. 2009 May-Jun; 33(3):327-35.
|
|
|
|
|
10.
|
Driscoll DF. The pharmacopeial evolution of intralipid injectable emulsion in plastic containers: from a coarse to a fine dispersion. Int J Pharm. 2009 Feb 23; 368(1-2):193-8.
|
|
|
|
|
11.
|
Driscoll DF, Ling PR, Silvestri AP, Bistrian BR. Fine vs. coarse complete all-in-one admixture infusions over 96 hours in rats: fat globule size and hepatic function. Clin Nutr. 2008 Dec; 27(6):889-94.
|
|
|
|
|
12.
|
Newton DW, Driscoll DF. Chemistry and safety of phosphates injections. Am J Health Syst Pharm. 2008 Sep 15; 65(18):1761-6.
|
|
|
|
|
13.
|
Driscoll DF, Bistrian BR, Demmelmair H, Koletzko B. Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology. Clin Nutr. 2008 Aug; 27(4):497-503.
|
|
|
|
|
14.
|
Newton DW, Driscoll DF. Calcium and phosphate compatibility: revisited again. Am J Health Syst Pharm. 2008 Jan 1; 65(1):73-80.
|
|
|
|
|
15.
|
Martin CR, Dumas GJ, Shoaie C, Zheng Z, Mackinnon B, Al-Aweel I, Bistrian BR, Pursley DM, Driscoll DF. Incidence of hypertriglyceridemia in critically ill neonates receiving lipid injectable emulsions in glass versus plastic containers: a retrospective analysis. J Pediatr. 2008 Feb; 152(2):232-6.
|
|
|
|
|
16.
|
Driscoll DF. Globule-size distribution in injectable 20% lipid emulsions: Compliance with USP requirements. Am J Health Syst Pharm. 2007 Oct 1; 64(19):2032-6.
|
|
|
|
|
17.
|
Driscoll DF, Ling PR, Bistrian BR. Physical stability of 20% lipid injectable emulsions via simulated syringe infusion: effects of glass vs plastic product packaging. JPEN J Parenter Enteral Nutr. 2007 Mar-Apr; 31(2):148-53.
|
|
|
|
|
18.
|
Driscoll DF, Silvestri AP, Bistrian BR, Mikrut BA. Stability of total nutrient admixtures with lipid injectable emulsions in glass versus plastic packaging. Am J Health Syst Pharm. 2007 Feb 15; 64(4):396-403.
|
|
|
|
|
19.
|
Driscoll DF, Parikh M, Silvestri AP, Klütsch K, Bistrian BR, Nehne J. Establishing a stability window for medium- and long-chain-triglyceride lipid-based total nutrient admixtures using USP standards. Am J Health Syst Pharm. 2006 Nov 1; 63(21):2135-43.
|
|
|
|
|
20.
|
Driscoll DF. Lipid injectable emulsions: Pharmacopeial and safety issues. Pharm Res. 2006 Sep; 23(9):1959-69.
|
|
|
|
|
21.
|
Driscoll DF. Lipid injectable emulsions: 2006. Nutr Clin Pract. 2006 Aug; 21(4):381-6.
|
|
|
|
|
22.
|
Driscoll DF, Ling PR, Bistrian BR. Pathological consequences to reticuloendothelial system organs following infusion of unstable all-in-one mixtures in rats. Clin Nutr. 2006 Oct; 25(5):842-50.
|
|
|
|
|
23.
|
Driscoll DF, Silvestri AP, Nehne J, Klütsch K, Bistrian BR, Niemann W. Physicochemical stability of highly concentrated total nutrient admixtures for fluid-restricted patients. Am J Health Syst Pharm. 2006 Jan 1; 63(1):79-85.
|
|
|
|
|
24.
|
Parikh MJ, Dumas G, Silvestri A, Bistrian BR, Driscoll DF. Physical compatibility of neonatal total parenteral nutrient admixtures containing organic calcium and inorganic phosphate salts. Am J Health Syst Pharm. 2005 Jun 1; 62(11):1177-83.
|
|
|
|
|
25.
|
Driscoll DF. Stability and compatibility assessment techniques for total parenteral nutrition admixtures: setting the bar according to pharmacopeial standards. Curr Opin Clin Nutr Metab Care. 2005 May; 8(3):297-303.
|
|
|
|
|
26.
|
Driscoll DF, Ling PR, Quist WC, Bistrian BR. Pathological consequences from the infusion of unstable lipid emulsion admixtures in guinea pigs. Clin Nutr. 2005 Feb; 24(1):105-13.
|
|
|
|
|
27.
|
Driscoll M, Driscoll DF. Calculating aluminum content in total parenteral nutrition admixtures. Am J Health Syst Pharm. 2005 Feb 1; 62(3):312-5.
|
|
|
|
|
28.
|
Driscoll DF, Dunbar JG, Marmarou A. Fat-globule size in a propofol emulsion containing sodium metabisulfite. Am J Health Syst Pharm. 2004 Jun 15; 61(12):1276-80.
|
|
|
|
|
29.
|
Driscoll DF, Driscoll JJ. At the bedside. America (NY). 2004 Jun 7- Jun 14; 190(19):29.
|
|
|
|
|
30.
|
Driscoll DF. Compounding TPN admixtures: then and now. JPEN J Parenter Enteral Nutr. 2003 Nov-Dec; 27(6):433-8; quiz 439.
|
|
|
|
|
31.
|
Driscoll DF, Nehne J, Peterss H, Klütsch K, Bistrian BR, Niemann W. Physicochemical stability of intravenous lipid emulsions as all-in-one admixtures intended for the very young. Clin Nutr. 2003 Oct; 22(5):489-95.
|
|
|
|
|
32.
|
Driscoll DF. Sterility of fat emulsion in plastic syringes. Am J Health Syst Pharm. 2003 Jan 15; 60(2):197; author reply 198.
|
|
|
|
|
33.
|
Sacks GS, Driscoll DF. Does lipid hang time make a difference? Time is of the essence. Nutr Clin Pract. 2002 Oct; 17(5):284-90.
|
|
|
|
|
34.
|
Driscoll DF, Nehne J, Peterss H, Franke R, Bistrian BR, Niemann W. The influence of medium-chain triglycerides on the stability of all-in-one formulations. Int J Pharm. 2002 Jun 20; 240(1-2):1-10.
|
|
|
|
|
35.
|
Driscoll DF, Etzler F, Barber TA, Nehne J, Niemann W, Bistrian BR. Physicochemical assessments of parenteral lipid emulsions: light obscuration versus laser diffraction. Int J Pharm. 2001 May 21; 219(1-2):21-37.
|
|
|
|
|
36.
|
Driscoll DF, Giampietro K, Wichelhaus DP, Peterss H, Nehne J, Niemann W, Bistrian BR. Physicochemical stability assessments of lipid emulsions of varying oil composition. Clin Nutr. 2001 Apr; 20(2):151-7.
|
|
|
|
|
37.
|
Driscoll DF. Drug-induced electrolyte disorders in patients receiving parenteral nutrition. JPEN J Parenter Enteral Nutr. 2000 May-Jun; 24(3):174-5.
|
|
|
|
|
38.
|
Driscoll DF, Bacon MN, Bistrian BR. Physicochemical stability of two types of intravenous lipid emulsion as total nutrient admixtures. JPEN J Parenter Enteral Nutr. 2000 Jan-Feb; 24(1):15-22.
|
|
|
|
|
39.
|
Pomposelli JJ, Baxter JK, Babineau TJ, Pomfret EA, Driscoll DF, Forse RA, Bistrian BR. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr. 1998 Mar-Apr; 22(2):77-81.
|
|
|
|
|
40.
|
Swails WS, Kenler AS, Driscoll DF, DeMichele SJ, Babineau TJ, Utsunamiya T, Chavali S, Forse RA, Bistrian BR. Effect of a fish oil structured lipid-based diet on prostaglandin release from mononuclear cells in cancer patients after surgery. JPEN J Parenter Enteral Nutr. 1997 Sep-Oct; 21(5):266-74.
|
|
|
|
|
41.
|
Driscoll DF. Is hospital pharmacy practice at a crossroad? Nutrition. 1997 Jun; 13(6):585-6.
|
|
|
|
|
42.
|
Driscoll DF. Physicochemical assessment of total nutrient admixture stability and safety: quantifying the risk. Nutrition. 1997 Feb; 13(2):166-7.
|
|
|
|
|
43.
|
Driscoll DF. Delivery of nutritional therapy: quality assurance of automated compounding devices. Nutrition. 1996 Sep; 12(9):651-2.
|
|
|
|
|
44.
|
Driscoll DF, Bacon MN, Bistrian BR. Effects of in-line filtration on lipid particle size distribution in total nutrient admixtures. JPEN J Parenter Enteral Nutr. 1996 Jul-Aug; 20(4):296-301.
|
|
|
|
|
45.
|
Mascioli EA, Lopes SM, Champagne C, Driscoll DF. Essential fatty acid deficiency and home total parenteral nutrition patients. Nutrition. 1996 Apr; 12(4):245-9.
|
|
|
|
|
46.
|
Driscoll DF. Ensuring the safety and efficacy of extemporaneously prepared infusions. Nutrition. 1996 Apr; 12(4):289-90.
|
|
|
|
|
47.
|
Allwood MC, Hardy G, Sizer T, Driscoll DF. Effects of air and oxygen on parenteral nutrition admixtures--an underrated risk? Nutrition. 1996 Mar; 12(3):222-3.
|
|
|
|
|
48.
|
Kenler AS, Swails WS, Driscoll DF, DeMichele SJ, Daley B, Babineau TJ, Peterson MB, Bistrian BR. Early enteral feeding in postsurgical cancer patients. Fish oil structured lipid-based polymeric formula versus a standard polymeric formula. Ann Surg. 1996 Mar; 223(3):316-33.
|
|
|
|
|
49.
|
Driscoll DF. Roles and functions of the hospital pharmacist on the nutrition support team. Nutrition. 1996 Feb; 12(2):138-9.
|
|
|
|
|
50.
|
Driscoll DF. Debate on total nutrient admixtures continues. Am J Health Syst Pharm. 1995 Sep 1; 52(17):1921-2.
|
|
|
|
|
51.
|
Driscoll DF. Total nutrient admixtures: theory and practice. Nutr Clin Pract. 1995 Jun; 10(3):114-9.
|
|
|
|
|
52.
|
Driscoll DF, Palombo JD, Bistrian BR. Nutritional and metabolic considerations of the adult liver transplant candidate and organ donor. Nutrition. 1995 May-Jun; 11(3):255-63.
|
|
|
|
|
53.
|
Driscoll DF. Use of total nutrient admixtures should not be limited. Am J Health Syst Pharm. 1995 Apr 15; 52(8):893-4; author reply 894-5.
|
|
|
|
|
54.
|
Driscoll DF, Bhargava HN, Li L, Zaim RH, Babayan VK, Bistrian BR. Physicochemical stability of total nutrient admixtures. Am J Health Syst Pharm. 1995 Mar 15; 52(6):623-34.
|
|
|
|
|
55.
|
Driscoll DF, Newton DW, Bistrian BR. Precipitation of calcium phosphate from parenteral nutrient fluids. Am J Hosp Pharm. 1994 Nov 15; 51(22):2834-6.
|
|
|
|
|
56.
|
Driscoll DF, Bacon M, Provost PS, Bistrian BR. Automated compounders for parenteral nutrition admixtures. JPEN J Parenter Enteral Nutr. 1994 Jul-Aug; 18(4):385-6.
|
|
|
|
|
57.
|
Daley BJ, Maliakkal RJ, Dreesen EB, Driscoll DF, Bistrian BR. Rapid clinical assessment of kidney function based on arm muscle circumference and serum creatinine. Nutrition. 1994 Mar-Apr; 10(2):128-31.
|
|
|
|
|
58.
|
Driscoll DF, Bistrian BR. Special considerations required for the formulation and administration of total parenteral nutrition therapy in the elderly patient. Drugs Aging. 1992 Sep-Oct; 2(5):395-405.
|
|
|
|
|
59.
|
Ye SL, Istfan NW, Driscoll DF, Bistrian BR. Tumor and host response to arginine and branched chain amino acid-enriched total parenteral nutrition. A study involving Walker 256 carcinosarcoma-bearing rats. Cancer. 1992 Jan 1; 69(1):261-70.
|
|
|
|
|
60.
|
Driscoll DF, Baptista RJ, Mitrano FP, Mascioli EA, Blackburn GL, Bistrian BR. Parenteral nutrient admixtures as drug vehicles: theory and practice in the critical care setting. DICP. 1991 Mar; 25(3):276-83.
|
|
|
|
|
61.
|
Driscoll DF, Blackburn GL. Total parenteral nutrition 1990. A review of its current status in hospitalised patients, and the need for patient-specific feeding. Drugs. 1990 Sep; 40(3):346-63.
|
|
|
|
|
62.
|
Driscoll DF, Lowell JA, Nompleggi D, Manji N, Lewis D, Bistrian BR. Continuous v intermittent cimetidine infusion in critically ill hospitalized patients: role of TPN admixture as drug vehicle. Nutrition. 1990 Sep-Oct; 6(5):383-8.
|
|
|
|
|
63.
|
Lowell JA, Schifferdecker C, Driscoll DF, Benotti PN, Bistrian BR. Postoperative fluid overload: not a benign problem. Crit Care Med. 1990 Jul; 18(7):728-33.
|
|
|
|
|
64.
|
Shikora SA, Driscoll DF, Bistrian BR. Metabolic alkalosis in a patient with renal failure: role of antacids. Nutr Rev. 1990 Jun; 48(6):247-50.
|
|
|
|
|
65.
|
Driscoll DF. Clinical issues regarding the use of total nutrient admixtures. DICP. 1990 Mar; 24(3):296-303.
|
|
|
|
|
66.
|
Driscoll DF, Pinson CW, Jenkins RL, Bistrian BR. Potential protective effects of furosemide against early renal injury in liver transplant patients receiving cyclosporine-A. Crit Care Med. 1989 Dec; 17(12):1341-3.
|
|
|
|
|
67.
|
McMahon M, Manji N, Driscoll DF, Bistrian BR. Parenteral nutrition in patients with diabetes mellitus: theoretical and practical considerations. JPEN J Parenter Enteral Nutr. 1989 Sep-Oct; 13(5):545-53.
|
|
|
|
|
68.
|
Driscoll DF, Pinson CW, Jenkins RL, Bistrian BR. Potential protective effects of furosemide against early cyclosporine-induced renal injury in hepatic transplant recipients. Transplant Proc. 1989 Jun; 21(3):3549-50.
|
|
|
|
|
69.
|
Driscoll DF. Drug-induced metabolic disorders and parenteral nutrition in the intensive care unit: a pharmaceutical and metabolic perspective. DICP. 1989 May; 23(5):363-71.
|
|
|
|
|
70.
|
Driscoll DF, McMahon M, Blackburn GL, Bistrian BR. Phenytoin toxicity in a critically ill, hypoalbuminemic patient with normal serum drug concentrations. Crit Care Med. 1988 Dec; 16(12):1248-9.
|
|
|
|
|
71.
|
Driscoll DF, Bistrian BR, Jenkins RL, Randall S, Dzik WH, Gerson B, Blackburn GL. Development of metabolic alkalosis after massive transfusion during orthotopic liver transplantation. Crit Care Med. 1987 Oct; 15(10):905-8.
|
|
|
|
|
72.
|
Driscoll DF, Bistrian BR. Clinical issues in the therapeutic monitoring of total parenteral nutrition. Clin Lab Med. 1987 Sep; 7(3):699-714.
|
|
|
|
|
73.
|
Baptista RJ, Driscoll DF, Gallagher JA, O'Keefe E, Dumas GJ, Hammer SM, Pacella PP. Infusion phlebitis associated with a programmable syringe-pump system versus gravity-feed minibottles. Clin Pharm. 1987 Apr; 6(4):314-8.
|
|
|
|
|
74.
|
Driscoll DF, Baptista RJ, Bistrian BR, Blackburn GL. Practical considerations regarding the use of total nutrient admixtures. Am J Hosp Pharm. 1986 Feb; 43(2):416-9.
|
|
|
|
|
75.
|
Newton DW, Driscoll DF, Goudreau JL, Ratanamaneichatara S. Solubility characteristics of diazepam in aqueous admixture solutions: theory and practice. Am J Hosp Pharm. 1981 Feb; 38(2):179-82.
|
|
|
|
